With Little Remaining Unmet Need for Injectable Biologics
Despite the increased efficacy of BMS’ Sotyktu over Amgen’s Otezla, dermatologists continue to express a desire for additional oral agents that bring...
Source: globenewswire.com
Page 4 - Spherix Network News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Spherix Network. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Spherix Network Today - Breaking & Trending Today
Another Medicine to Stop Migraine in its Tracks – Zavzpret™
Will Pfizer’s marketing power help Zavzpret™ rapidly gain share in the crowded migraine market?...
Source: globenewswire.com
An Old Dog with a New Trick… Ellodi's APT-1011 Promises EoE
Spherix Global Insights finds doctors have yet to define where APT-1011 will sit in the treatment path relative to EoE treatment gold standard, Dupixent....
Source: globenewswire.com
How High Is the Bar for Future ALS Treatments? Although Neurologists Express Frustration with ...
Exton, Pennsylvania, Aug. 02, 2023 (GLOBE NEWSWIRE) -- A quiet but significant advance was made during the last year: not one, but two medicines were FDA approved to delay disease
Source: eagletribune.com
First-to-Market Edge for Apellis's Syfovre in Geographic
Prospects for Syfovre uptake and trust in Apellis take a plunge following reports of intraocular inflammation, according to Spherix Global Insights...
Source: globenewswire.com